iShares Global Healthcare ETFiShares Global Healthcare ETFiShares Global Healthcare ETF

iShares Global Healthcare ETF

No trades
No trades

Key stats


Assets under management (AUM)
‪4.13 B‬USD
Fund flows (1Y)
‪−280.97 M‬USD
Dividend yield (indicated)
1.44%
Discount/Premium to NAV
0.06%
Shares outstanding
‪40.85 M‬
Expense ratio
0.40%

Details


Brand
iShares
Home page
Inception date
Nov 13, 2001
Structure
Open-Ended Fund
Index tracked
S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
BlackRock Fund Advisors
Distributor
BlackRock Investments LLC
ISIN
US4642873255
CUSIP
464287325
FIGI
BBG000L77VV0
Identifiers
ISIN US4642873255
CFI code
CEOJLS
IXJ offers exposure to the global healthcare sector as defined by GICS. The fund pulls from the S&P Global 1200 universe, which effectively screens out small-caps, giving the fund a large-cap tilt. The fund advisors use a sampling approach to indexing. This means the fund may not hold all the stocks of the underlying index but will hold securities that collectively have the same investment profile. The index is weighted by float-adjusted market-cap. It is rebalanced quarterly to cap the aggregate weight of all issuers that individually exceed 4.5% of the index weight to a maximum of 22.5%. Before Sep. 20, 2021, the fund tracked the Dow Jones U.S. Health Care Index and until Mar. 23, 2026, it tracked the S&P Global 1200 Health Care Index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
Global
Weighting scheme
Market cap
Selection criteria
Committee

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of July 31, 2026
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.80%
Health Technology84.53%
Health Services9.92%
Distribution Services2.88%
Retail Trade1.70%
Technology Services0.39%
Commercial Services0.37%
Bonds, Cash & Other0.20%
Mutual fund0.14%
Cash0.07%
Corporate0.00%
Breakdown by region
0.9%0.1%69%25%3%
North America69.99%
Europe25.10%
Asia3.97%
Oceania0.86%
Latin America0.09%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently asked questions


IXJ invests in stocks. The fund's major sectors are Health Technology, with 84.53% stocks, and Health Services, with 9.92% of the basket. The assets are mostly located in the North America region.
IXJ top holdings are Eli Lilly and Company and Johnson & Johnson, occupying 10.31% and 7.00% of the portfolio correspondingly.
IXJ last dividends amounted to 0.85 USD. Six months before that, the issuer paid 0.60 USD in dividends, which shows a 29.36% increase.
IXJ assets under management is ‪4.13 B‬ USD. It's fallen 0.93% over the last month.
IXJ fund flows account for ‪−280.97 M‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, IXJ pays dividends to its holders with the dividend yield of 1.44%. The last dividend (Jun 18, 2026) amounted to 0.85 USD. The dividends are paid semi-annually.
IXJ shares are issued by BlackRock, Inc. under the brand iShares. The ETF was launched on Nov 13, 2001, and its management style is Passive.
IXJ expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
IXJ follows the S&P Global 1200 Health Care Sector Capped Index - USD - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
IXJ invests in stocks.
IXJ price has risen by 1.61% over the last month, and its yearly performance shows a 20.37% increase. See more dynamics on IXJ price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 1.25% over the last month, showed a 9.46% increase in three-month performance and has increased by 21.16% in a year.
IXJ trades at a premium (0.14%) meaning the ETF is trading at a higher price than the calculated NAV.